An isocratic liquid chromatography method for determining HIV non-nucleoside reverse transcriptase inhibitor and protease inhibitor concentrations in human plasma

Transcriptase Inhibitor ◽

Chromatography Method ◽

Liquid Chromatography Method ◽

Development and validation of a high performance liquid chromatography method for determination of 6-benzyl-1-benzyloxymethyl-5-iodouracil (W-1), a novel non-nucleoside reverse transcriptase inhibitor and its application to a pharmacokinetic study in rats

Biomedical Chromatography ◽

10.1002/bmc.3457 ◽

2015 ◽

Vol 29 (10) ◽

pp. 1548-1552 ◽

Cited By ~ 4

Author(s):

Ying-Yuan Lu ◽

Xin Wang ◽

Xiao-Wei Wang ◽

Jun-Yi Liu ◽

Pu Li ◽

...

Keyword(s):

High Performance Liquid Chromatography ◽

Liquid Chromatography ◽

High Performance ◽

Transcriptase Inhibitor ◽

Chromatography Method ◽

Liquid Chromatography Method ◽

Development And Validation ◽

High Performance Liquid Chromatography Using UV Detection for the Simultaneous Quantification of the New Non-nucleoside Reverse Transcriptase Inhibitor Etravirine (TMC-125), and 4 Protease Inhibitors in Human Plasma

Biological and Pharmaceutical Bulletin ◽

10.1248/bpb.33.1426 ◽

2010 ◽

Vol 33 (8) ◽

pp. 1426-1429 ◽

Cited By ~ 10

Author(s):

Atsushi Hirano ◽

Masaaki Takahashi ◽

Eri Kinoshita ◽

Masaaki Shibata ◽

Toshiharu Nomura ◽

...

Keyword(s):

High Performance Liquid Chromatography ◽

Liquid Chromatography ◽

Reverse Transcriptase ◽

Human Plasma ◽

Protease Inhibitors ◽

High Performance ◽

Transcriptase Inhibitor ◽

Simultaneous Quantification ◽

Liquid chromatography–tandem mass spectrometric assay for the nucleoside reverse transcriptase inhibitor emtricitabine in human plasma

Biomedical Chromatography ◽

10.1002/bmc.797 ◽

2007 ◽

Vol 21 (6) ◽

pp. 621-627 ◽

Cited By ~ 10

Author(s):

Rolf W. Sparidans ◽

Jan M. Prins ◽

Jan H.M. Schellens ◽

Jos H. Beijnen

Keyword(s):

Liquid Chromatography ◽

Reverse Transcriptase ◽

Human Plasma ◽

Transcriptase Inhibitor ◽

Mass Spectrometric ◽

Tandem Mass ◽

Liquid Chromatography Tandem Mass ◽

Tandem Mass Spectrometric ◽

Liquid chromatography-tandem mass spectrometric assay for the non-nucleoside reverse transcriptase inhibitor rilpivirine in human plasma

Biomedical Chromatography ◽

10.1002/bmc.2765 ◽

2012 ◽

Vol 27 (2) ◽

pp. 172-178 ◽

Cited By ~ 15

Author(s):

Laxminarayana Burugula ◽

Nageswara Rao Pilli ◽

Ajitha Makula ◽

Durga Srinivas Lodagala ◽

Rajnarayana Kandhagatla

Keyword(s):

Liquid Chromatography ◽

Reverse Transcriptase ◽

Human Plasma ◽

Transcriptase Inhibitor ◽

Mass Spectrometric ◽

Tandem Mass ◽

Liquid Chromatography Tandem Mass ◽

Tandem Mass Spectrometric ◽

Immune Reconstitution Is Comparable in Antiretroviral‐Naive Subjects after 1 Year of Successful Therapy with a Nucleoside Reverse‐Transcriptase Inhibitor– or Protease Inhibitor–Containing Antiretroviral Regimen

The Journal of Infectious Diseases ◽

10.1086/379041 ◽

2003 ◽

Vol 188 (10) ◽

pp. 1444-1454 ◽

Cited By ~ 24

Author(s):

Alan L. Landay ◽

John Spritzler ◽

Harold Kessler ◽

Donna Mildvan ◽

Minya Pu ◽

...

Keyword(s):

Protease Inhibitor ◽

Reverse Transcriptase ◽

Immune Reconstitution ◽

Transcriptase Inhibitor ◽

Successful Therapy ◽

Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial

The Lancet ◽

10.1016/s0140-6736(06)69074-0 ◽

2006 ◽

Vol 368 (9532) ◽

pp. 287-298 ◽

Cited By ~ 60

Keyword(s):

Antiretroviral Therapy ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Randomised Trial ◽

Transcriptase Inhibitor ◽

Open Label ◽

Malaria in HIV-Infected Children Receiving HIV Protease-Inhibitor- Compared with Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy, IMPAACT P1068s, Substudy to P1060

PLoS ONE ◽

10.1371/journal.pone.0165140 ◽

2016 ◽

Vol 11 (12) ◽

pp. e0165140 ◽

Cited By ~ 8

Author(s):

Charlotte V. Hobbs ◽

Erin E. Gabriel ◽

Portia Kamthunzi ◽

Gerald Tegha ◽

Jean Tauzie ◽

...

Keyword(s):

Antiretroviral Therapy ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Hiv Protease ◽

Hiv Protease Inhibitor ◽

The choice between a ritonavir-boosted protease inhibitor- and a non-nucleoside reverse transcriptase inhibitor-based regimen for initiation of antiretroviral treatment – results from an observational study in Germany

Journal of Pharmaceutical Policy and Practice ◽

10.1186/s40545-016-0092-4 ◽

2016 ◽

Vol 9 (1) ◽

Cited By ~ 1

Author(s):

Jörg Mahlich ◽

Mona Groß ◽

Alexander Kuhlmann ◽

Johannes Bogner ◽

Hans Heiken ◽

...

Keyword(s):

Observational Study ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Antiretroviral Treatment ◽

Transcriptase Inhibitor ◽

Treatment Results ◽

Second-line protease inhibitor-based highly active antiretroviral therapy after failing non-nucleoside reverse transcriptase inhibitor-based regimens in Asian HIV-infected children

Antiviral Therapy ◽

10.3851/imp2494 ◽

2013 ◽

Vol 18 (4) ◽

pp. 591-598 ◽

Cited By ~ 8

Author(s):

Torsak Bunupuradah ◽

◽

Thanyawee Puthanakit ◽

Paul Fahey ◽

Azar Kariminia ◽

...

Keyword(s):

Antiretroviral Therapy ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Highly Active Antiretroviral Therapy ◽

Transcriptase Inhibitor ◽

Second Line ◽

Highly Active ◽

Salvage therapy with abacavir plus a non-nucleoside reverse transcriptase inhibitor and a protease inhibitor in heavily pre-treated HIV-1 infected patients

AIDS ◽

10.1097/00002030-200005050-00004 ◽

2000 ◽

Vol 14 (7) ◽

pp. 791-799 ◽

Cited By ~ 26

Author(s):

Nina Khanna ◽

Thomas Klimkait ◽

Veronique Schiffer ◽

Jose Irigoyen ◽

Amalio Telenti ◽

...

Keyword(s):

Protease Inhibitor ◽

Reverse Transcriptase ◽

Salvage Therapy ◽

Transcriptase Inhibitor ◽

Reverse Transcriptase Inhibitor ◽

Hiv 1